Nonmyeloablative allogeneic stem-cell transplantation for hematologic malignancies: a systematic review (Q35071096)

6 August 2017

1 reference

title

Nonmyeloablative allogeneic stem-cell transplantation for hematologic malignancies: a systematic review (English)

1 reference

6 August 2017

1 reference

1

Benjamin Djulbegovic

1 reference

6 August 2017

Jerome Seidenfeld

2

1 reference

6 August 2017

Claudia Bonnell

series ordinal

3

1 reference

6 August 2017

Ambuj Kumar

series ordinal

4

1 reference

6 August 2017

publication date

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

10

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

17-41

1 reference

The use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancer

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000104

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000104

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000104

Treatment of relapse after allogeneic bone marrow transplantation with reduced intensity conditioning (FLAG +/- Ida) and second allogeneic stem cell transplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000104

Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000104

Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000104

Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000104

Hematopoietic stem cell allografts using a non-myeloablative conditioning regimen can be safely performed on an outpatient basis: report of four cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000104

Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000104

Reduced intensity conditioning: enhanced graft-versus-tumor effect following dose-reduced conditioning and allogeneic transplantation for refractory lymphoid malignancies after high-dose therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000104

Nonmyeloablative stem cell transplantation with CD8-depleted or CD34-selected peripheral blood stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000104

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000104

Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000104

Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000104

Results of an outpatient-based stem cell allotransplant program using nonmyeloablative conditioning regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000104

10.1177/107327480301000104

21 January 2018

Identifiers

DOI

0 references

1 reference